Functional Outcomes in Head and Neck Cancer Patients
With the increase in long-term survivorship of head and neck cancer (HNC), the functional outcomes are gaining importance. We reported the functional outcomes of HNC patients using the HNC-Functional InTegrity (FIT) Scales, which is a validated tool for the rapid clinical assessment of functional st...
Gespeichert in:
Veröffentlicht in: | Cancers 2022-04, Vol.14 (9), p.2135 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 9 |
container_start_page | 2135 |
container_title | Cancers |
container_volume | 14 |
creator | Riechelmann, Herbert Dejaco, Daniel Steinbichler, Teresa Bernadette Lettenbichler-Haug, Anna Anegg, Maria Ganswindt, Ute Gamerith, Gabriele Riedl, David |
description | With the increase in long-term survivorship of head and neck cancer (HNC), the functional outcomes are gaining importance. We reported the functional outcomes of HNC patients using the HNC-Functional InTegrity (FIT) Scales, which is a validated tool for the rapid clinical assessment of functional status based on observable clinical criteria. Patients with newly diagnosed HNC treated at the Medical University of Innsbruck between 2008 and 2020 were consecutively included, and their status in the six functional domains of food-intake, breathing, speech, pain, mood, and neck and shoulder mobility was scored by the treating physician at oncological follow-up visits on a scale from 0 (loss of function) to 4 (full function). HNC-FIT scales were available for 681 HNC patients at a median of 35 months after diagnosis. The response status was complete remission in 79.5%, 18.1% had recurrent or persistent disease, and 2.4% had a second primary HNC. Normal or near-normal scores (3 and 4) were seen in 78.6% for food intake, 88.7% for breathing, 83.7% for speech, 89% for pain, 91.8% for mood, and 87.5% for neck and shoulder mobility. A normal or near-normal outcome in all six functional domains was observed in 61% of patients. Clinically relevant impairment (score 1-2) in at least one functional domain was observed in 30%, and 9% had loss of function (score 0) in at least one functional domain. The main factors associated with poor functional outcome in a multivariable analysis were recurrence or persistent disease, poor general health (ASA III and IV), and higher T stage. Particularly, laryngeal and hypopharyngeal tumors impaired breathing and speech function, and primary radiation therapy or concomitant systemic therapy and radiotherapy worsened food intake. Clinically relevant persistent functional deficits in at least one functional domain must be expected in 40% of the patients with HNC. The treatment of these functional deficits is an essential task of oncologic follow-up. |
doi_str_mv | 10.3390/cancers14092135 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9099625</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2662957028</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351t-7523d1098954809a11cc1eaa8cc68c4b433cfc00fce438147ca657c97720046d3</originalsourceid><addsrcrecordid>eNpdkU1LAzEQhoMottSevcmCFy-r-c7mIkixVijWg55DOpvVrdtNTXYF_71rW0ttLhOYZ975eBE6J_iaMY1vwNbgQiQca0qYOEJ9ihVNpdT8eO_fQ8MYF7h7jBEl1SnqMSGkoFL0ER-3NTSlr22VzNoG_NLFpKyTibN5Yus8eXLwkYzWnZJn25SubuIZOilsFd1wGwfodXz_Mpqk09nD4-humgITpEmVoCwnWGda8AxrSwgAcdZmADIDPueMQQEYF-A4ywhXYKVQoJWiGHOZswG63eiu2vnS5dD1DrYyq1Aubfg23pbmf6Yu382b_zIaay2p6ASutgLBf7YuNmZZRnBVZWvn22iolFxpSQjp0MsDdOHb0J1lTVEtFKZZR91sKAg-xuCK3TAEm19TzIEpXcXF_g47_s8C9gMQ7IdI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2662957028</pqid></control><display><type>article</type><title>Functional Outcomes in Head and Neck Cancer Patients</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Riechelmann, Herbert ; Dejaco, Daniel ; Steinbichler, Teresa Bernadette ; Lettenbichler-Haug, Anna ; Anegg, Maria ; Ganswindt, Ute ; Gamerith, Gabriele ; Riedl, David</creator><creatorcontrib>Riechelmann, Herbert ; Dejaco, Daniel ; Steinbichler, Teresa Bernadette ; Lettenbichler-Haug, Anna ; Anegg, Maria ; Ganswindt, Ute ; Gamerith, Gabriele ; Riedl, David</creatorcontrib><description>With the increase in long-term survivorship of head and neck cancer (HNC), the functional outcomes are gaining importance. We reported the functional outcomes of HNC patients using the HNC-Functional InTegrity (FIT) Scales, which is a validated tool for the rapid clinical assessment of functional status based on observable clinical criteria. Patients with newly diagnosed HNC treated at the Medical University of Innsbruck between 2008 and 2020 were consecutively included, and their status in the six functional domains of food-intake, breathing, speech, pain, mood, and neck and shoulder mobility was scored by the treating physician at oncological follow-up visits on a scale from 0 (loss of function) to 4 (full function). HNC-FIT scales were available for 681 HNC patients at a median of 35 months after diagnosis. The response status was complete remission in 79.5%, 18.1% had recurrent or persistent disease, and 2.4% had a second primary HNC. Normal or near-normal scores (3 and 4) were seen in 78.6% for food intake, 88.7% for breathing, 83.7% for speech, 89% for pain, 91.8% for mood, and 87.5% for neck and shoulder mobility. A normal or near-normal outcome in all six functional domains was observed in 61% of patients. Clinically relevant impairment (score 1-2) in at least one functional domain was observed in 30%, and 9% had loss of function (score 0) in at least one functional domain. The main factors associated with poor functional outcome in a multivariable analysis were recurrence or persistent disease, poor general health (ASA III and IV), and higher T stage. Particularly, laryngeal and hypopharyngeal tumors impaired breathing and speech function, and primary radiation therapy or concomitant systemic therapy and radiotherapy worsened food intake. Clinically relevant persistent functional deficits in at least one functional domain must be expected in 40% of the patients with HNC. The treatment of these functional deficits is an essential task of oncologic follow-up.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers14092135</identifier><identifier>PMID: 35565265</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Cancer therapies ; Food intake ; Gender ; Head & neck cancer ; Interdisciplinary aspects ; Lymphatic system ; Metastasis ; Mobility ; Mood ; Ostomy ; Otolaryngology ; Pain ; Patients ; Radiation therapy ; Remission ; Risk factors ; Shoulder ; Speech ; Surgery ; Survival ; Tumors</subject><ispartof>Cancers, 2022-04, Vol.14 (9), p.2135</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c351t-7523d1098954809a11cc1eaa8cc68c4b433cfc00fce438147ca657c97720046d3</citedby><cites>FETCH-LOGICAL-c351t-7523d1098954809a11cc1eaa8cc68c4b433cfc00fce438147ca657c97720046d3</cites><orcidid>0000-0001-7025-9729 ; 0000-0001-9176-7415 ; 0000-0003-0518-3144</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099625/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099625/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35565265$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Riechelmann, Herbert</creatorcontrib><creatorcontrib>Dejaco, Daniel</creatorcontrib><creatorcontrib>Steinbichler, Teresa Bernadette</creatorcontrib><creatorcontrib>Lettenbichler-Haug, Anna</creatorcontrib><creatorcontrib>Anegg, Maria</creatorcontrib><creatorcontrib>Ganswindt, Ute</creatorcontrib><creatorcontrib>Gamerith, Gabriele</creatorcontrib><creatorcontrib>Riedl, David</creatorcontrib><title>Functional Outcomes in Head and Neck Cancer Patients</title><title>Cancers</title><addtitle>Cancers (Basel)</addtitle><description>With the increase in long-term survivorship of head and neck cancer (HNC), the functional outcomes are gaining importance. We reported the functional outcomes of HNC patients using the HNC-Functional InTegrity (FIT) Scales, which is a validated tool for the rapid clinical assessment of functional status based on observable clinical criteria. Patients with newly diagnosed HNC treated at the Medical University of Innsbruck between 2008 and 2020 were consecutively included, and their status in the six functional domains of food-intake, breathing, speech, pain, mood, and neck and shoulder mobility was scored by the treating physician at oncological follow-up visits on a scale from 0 (loss of function) to 4 (full function). HNC-FIT scales were available for 681 HNC patients at a median of 35 months after diagnosis. The response status was complete remission in 79.5%, 18.1% had recurrent or persistent disease, and 2.4% had a second primary HNC. Normal or near-normal scores (3 and 4) were seen in 78.6% for food intake, 88.7% for breathing, 83.7% for speech, 89% for pain, 91.8% for mood, and 87.5% for neck and shoulder mobility. A normal or near-normal outcome in all six functional domains was observed in 61% of patients. Clinically relevant impairment (score 1-2) in at least one functional domain was observed in 30%, and 9% had loss of function (score 0) in at least one functional domain. The main factors associated with poor functional outcome in a multivariable analysis were recurrence or persistent disease, poor general health (ASA III and IV), and higher T stage. Particularly, laryngeal and hypopharyngeal tumors impaired breathing and speech function, and primary radiation therapy or concomitant systemic therapy and radiotherapy worsened food intake. Clinically relevant persistent functional deficits in at least one functional domain must be expected in 40% of the patients with HNC. The treatment of these functional deficits is an essential task of oncologic follow-up.</description><subject>Cancer therapies</subject><subject>Food intake</subject><subject>Gender</subject><subject>Head & neck cancer</subject><subject>Interdisciplinary aspects</subject><subject>Lymphatic system</subject><subject>Metastasis</subject><subject>Mobility</subject><subject>Mood</subject><subject>Ostomy</subject><subject>Otolaryngology</subject><subject>Pain</subject><subject>Patients</subject><subject>Radiation therapy</subject><subject>Remission</subject><subject>Risk factors</subject><subject>Shoulder</subject><subject>Speech</subject><subject>Surgery</subject><subject>Survival</subject><subject>Tumors</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkU1LAzEQhoMottSevcmCFy-r-c7mIkixVijWg55DOpvVrdtNTXYF_71rW0ttLhOYZ975eBE6J_iaMY1vwNbgQiQca0qYOEJ9ihVNpdT8eO_fQ8MYF7h7jBEl1SnqMSGkoFL0ER-3NTSlr22VzNoG_NLFpKyTibN5Yus8eXLwkYzWnZJn25SubuIZOilsFd1wGwfodXz_Mpqk09nD4-humgITpEmVoCwnWGda8AxrSwgAcdZmADIDPueMQQEYF-A4ywhXYKVQoJWiGHOZswG63eiu2vnS5dD1DrYyq1Aubfg23pbmf6Yu382b_zIaay2p6ASutgLBf7YuNmZZRnBVZWvn22iolFxpSQjp0MsDdOHb0J1lTVEtFKZZR91sKAg-xuCK3TAEm19TzIEpXcXF_g47_s8C9gMQ7IdI</recordid><startdate>20220425</startdate><enddate>20220425</enddate><creator>Riechelmann, Herbert</creator><creator>Dejaco, Daniel</creator><creator>Steinbichler, Teresa Bernadette</creator><creator>Lettenbichler-Haug, Anna</creator><creator>Anegg, Maria</creator><creator>Ganswindt, Ute</creator><creator>Gamerith, Gabriele</creator><creator>Riedl, David</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7025-9729</orcidid><orcidid>https://orcid.org/0000-0001-9176-7415</orcidid><orcidid>https://orcid.org/0000-0003-0518-3144</orcidid></search><sort><creationdate>20220425</creationdate><title>Functional Outcomes in Head and Neck Cancer Patients</title><author>Riechelmann, Herbert ; Dejaco, Daniel ; Steinbichler, Teresa Bernadette ; Lettenbichler-Haug, Anna ; Anegg, Maria ; Ganswindt, Ute ; Gamerith, Gabriele ; Riedl, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351t-7523d1098954809a11cc1eaa8cc68c4b433cfc00fce438147ca657c97720046d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Cancer therapies</topic><topic>Food intake</topic><topic>Gender</topic><topic>Head & neck cancer</topic><topic>Interdisciplinary aspects</topic><topic>Lymphatic system</topic><topic>Metastasis</topic><topic>Mobility</topic><topic>Mood</topic><topic>Ostomy</topic><topic>Otolaryngology</topic><topic>Pain</topic><topic>Patients</topic><topic>Radiation therapy</topic><topic>Remission</topic><topic>Risk factors</topic><topic>Shoulder</topic><topic>Speech</topic><topic>Surgery</topic><topic>Survival</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Riechelmann, Herbert</creatorcontrib><creatorcontrib>Dejaco, Daniel</creatorcontrib><creatorcontrib>Steinbichler, Teresa Bernadette</creatorcontrib><creatorcontrib>Lettenbichler-Haug, Anna</creatorcontrib><creatorcontrib>Anegg, Maria</creatorcontrib><creatorcontrib>Ganswindt, Ute</creatorcontrib><creatorcontrib>Gamerith, Gabriele</creatorcontrib><creatorcontrib>Riedl, David</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Riechelmann, Herbert</au><au>Dejaco, Daniel</au><au>Steinbichler, Teresa Bernadette</au><au>Lettenbichler-Haug, Anna</au><au>Anegg, Maria</au><au>Ganswindt, Ute</au><au>Gamerith, Gabriele</au><au>Riedl, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functional Outcomes in Head and Neck Cancer Patients</atitle><jtitle>Cancers</jtitle><addtitle>Cancers (Basel)</addtitle><date>2022-04-25</date><risdate>2022</risdate><volume>14</volume><issue>9</issue><spage>2135</spage><pages>2135-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>With the increase in long-term survivorship of head and neck cancer (HNC), the functional outcomes are gaining importance. We reported the functional outcomes of HNC patients using the HNC-Functional InTegrity (FIT) Scales, which is a validated tool for the rapid clinical assessment of functional status based on observable clinical criteria. Patients with newly diagnosed HNC treated at the Medical University of Innsbruck between 2008 and 2020 were consecutively included, and their status in the six functional domains of food-intake, breathing, speech, pain, mood, and neck and shoulder mobility was scored by the treating physician at oncological follow-up visits on a scale from 0 (loss of function) to 4 (full function). HNC-FIT scales were available for 681 HNC patients at a median of 35 months after diagnosis. The response status was complete remission in 79.5%, 18.1% had recurrent or persistent disease, and 2.4% had a second primary HNC. Normal or near-normal scores (3 and 4) were seen in 78.6% for food intake, 88.7% for breathing, 83.7% for speech, 89% for pain, 91.8% for mood, and 87.5% for neck and shoulder mobility. A normal or near-normal outcome in all six functional domains was observed in 61% of patients. Clinically relevant impairment (score 1-2) in at least one functional domain was observed in 30%, and 9% had loss of function (score 0) in at least one functional domain. The main factors associated with poor functional outcome in a multivariable analysis were recurrence or persistent disease, poor general health (ASA III and IV), and higher T stage. Particularly, laryngeal and hypopharyngeal tumors impaired breathing and speech function, and primary radiation therapy or concomitant systemic therapy and radiotherapy worsened food intake. Clinically relevant persistent functional deficits in at least one functional domain must be expected in 40% of the patients with HNC. The treatment of these functional deficits is an essential task of oncologic follow-up.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35565265</pmid><doi>10.3390/cancers14092135</doi><orcidid>https://orcid.org/0000-0001-7025-9729</orcidid><orcidid>https://orcid.org/0000-0001-9176-7415</orcidid><orcidid>https://orcid.org/0000-0003-0518-3144</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2072-6694 |
ispartof | Cancers, 2022-04, Vol.14 (9), p.2135 |
issn | 2072-6694 2072-6694 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9099625 |
source | MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access |
subjects | Cancer therapies Food intake Gender Head & neck cancer Interdisciplinary aspects Lymphatic system Metastasis Mobility Mood Ostomy Otolaryngology Pain Patients Radiation therapy Remission Risk factors Shoulder Speech Surgery Survival Tumors |
title | Functional Outcomes in Head and Neck Cancer Patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T03%3A22%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functional%20Outcomes%20in%20Head%20and%20Neck%20Cancer%20Patients&rft.jtitle=Cancers&rft.au=Riechelmann,%20Herbert&rft.date=2022-04-25&rft.volume=14&rft.issue=9&rft.spage=2135&rft.pages=2135-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers14092135&rft_dat=%3Cproquest_pubme%3E2662957028%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2662957028&rft_id=info:pmid/35565265&rfr_iscdi=true |